ストックスクリーナーアプリを入手
52.65
10.84%
5.15
アフターアワーズ：
52.75
0.10
+0.19%
Uniqure N V (QURE) 最新ニュース
uniQure announces pricing of upsized $300M public offering - msn.com
uniQure (QURE) Raises $300M from Public Offering - GuruFocus
uniQure prices public offering of shares at $47.50, aims to raise $300m - Investing.com
$300 Million Capital Raise: Gene Therapy Leader uniQure Prices Upsized Public Offering with Warrants - Stock Titan
uniQure N.V. Announces Pricing of $300 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - Quiver Quantitative
UniQure Announces Pricing of Upsized $300 Million Public Offering - MarketScreener
UniQure Stock Skyrockets: Breaking New Ground? - timothysykes.com
UniQure data suggest Huntington’s breakthrough as $200m raise follows - The Pharma Letter
Phase 1/2 Trial for uniQure's Huntington Disease Gene Therapy AMT-130 Hits Primary End Point - CGTLive®
uniQure (QURE) Receives Neutral Rating with Major Price Target I - GuruFocus
uniQure (NASDAQ:QURE) Price Target Raised to $56.00 at The Goldman Sachs Group - MarketBeat
Mizuho Ups Price Target for uniQure (QURE) to $60, Maintains Out - GuruFocus
Positive Phase I/II study results for Huntington’s disease gene therapy - RegMedNet
UniQure extends eye-watering rally ahead of planned $200 mln share offering - TradingView
uniQure stock rises after positive Huntington’s disease gene therapy data - Investing.com India
QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study - TradingView
Wells Fargo Raises uniQure (QURE) Price Target to $65 | QURE Sto - GuruFocus
Uniqure (QURE) Soars 275% on Stellar Clinical Trial for Huntington’s Disease - MSN
uniQure (NASDAQ:QURE) Shares Gap Up on Analyst Upgrade - MarketBeat
Uniqure NV stock hits 52-week high at 51.67 USD - Investing.com India
Wells Fargo & Company Boosts uniQure (NASDAQ:QURE) Price Target to $65.00 - MarketBeat
uniQure (QURE) Stock: Gene Therapy Results Drive 220% Weekly Rally - parameter.io
uniQure (QURE) Target Price Raised by Guggenheim Analyst | QURE Stock News - GuruFocus
uniQure (QURE) Receives Optimistic Analyst Ratings | QURE Stock News - GuruFocus
Uniqure NV stock hits 52-week high at 51.67 USD By Investing.com - Investing.com UK
Guggenheim Forecasts Strong Price Appreciation for uniQure (NASDAQ:QURE) Stock - MarketBeat
uniQure (NASDAQ:QURE) Given New $80.00 Price Target at Cantor Fitzgerald - MarketBeat
Will QURE’s Stock Continue to Soar? - timothysykes.com
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus - Morningstar
A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $55 to $95 - 富途牛牛
UniQure Stock's 248% Blastoff Was Just The Start — Ask Wall Street - Benzinga
uniQure (QURE): Chardan Capital Raises Price Target to $76 Follo - GuruFocus
uniQure (NASDAQ:QURE) Given New $76.00 Price Target at Chardan Capital - MarketBeat
Chardan Capital Maintains uniQure N.V. (QURE) Buy Recommendation - Nasdaq
Chardan Boosts Price Target on uniQure to $76 From $35, Keeps Buy Rating - MarketScreener
uniQure Stock Jumps On Positive News, But Risks Remain - Benzinga
UniQure stock surges 247% after mid-stage Huntington’s win - Yahoo Finance
uniQure instigates $200 million proposed public offering - The Pharma Letter
Strength Seen in uniQure (QURE): Can Its 247.7% Jump Turn into More Strength? - Nasdaq
UniQure Stock (QURE) Rallying – Analysts Upgrade on Huntington’s Gene Therapy Data - AskTraders.com
uniQure stock price target doubled to $60 by Mizuho on Huntington’s therapy data - Investing.com UK
uniQure Announces Positive Results for Huntington’s Study - TipRanks
UniQure’s stocks up after AMT-130 trial win - European Biotechnology Magazine
Alibaba, Intel, Uniqure, Tesla And Opendoor: Why These 5 Stocks Are On Investors' Radars Today - inkl
BABA, INTC, QURE, TSLA, OPEN: 5 Trending Stocks TodayAlibaba Gr Hldgs (NYSE:BABA), Intel (NASDAQ:INTC) - Benzinga
Top Stocks today: uniQure, Lithium Americas and Tesla soar - Yahoo Finance
uniQure launches $200 million public offering of ordinary shares By Investing.com - Investing.com Australia
uniQure stock soars after positive Huntington’s disease drug results - Investing.com
uniQure (QURE) Stock: Soars 247% on $200 Million Public Offering Plan - parameter.io
uniQure (QURE) Analyst Raises Price Target to $68 With Outperform Rating | QURE Stock News - GuruFocus
UniQure Stock Soars: Too Late to Buy? - timothysykes.com
Top stocks today: Tesla, uniQure, and Lithium Americas soar - TheStreet
Here’s why biotech UniQure’s stock just tripled, and brought ClearPoint shares up with it - MSN
uniQure (QURE) Launches $200M Public Offering, Sees After-Hours Stock Surge - GuruFocus
Experimental gene therapy found to slow Huntington’s disease progression, company says - CNN
UniQure Stock Hits 5-Year High As Analysts Hail Huntington’s Therapy Data — Retail Spots ‘Diamond In Rough Of Biotech’ - Stocktwits
uniQure launches $200 million public offering of ordinary shares - Investing.com
Uniqure stock soars over 247% today after breakthrough Huntington’s disease drug results - The Economic Times
UniQure launches $200 mln equity offering after shares skyrocket - TradingView
uniQure (QURE) Initiates $200 Million Public Offering - GuruFocus
uniQure announces $200 million proposed public offering - msn.com
uniQure announces $200M ordinary shares offering - TipRanks
UniQure Huntington’s Gene Therapy Launch Planning Underway - insights.citeline.com
uniQure Announces $200 Million Proposed Public Offering - The Manila Times
uniQure: Positive 3-Year AMT-130 Data Leads To Pre-BLA FDA Meeting And Beyond (QURE) - Seeking Alpha
Hunting down Huntington’s: Uniqure’s pivotal win - BioWorld MedTech
UniQure Celebrates A Groundbreaking Moment For Huntington’s Disease - insights.citeline.com
$200 Million Share Offering: Gene Therapy Leader uniQure Seeks Capital for Transformative Therapies - Stock Titan
Promising Medical Stocks To Watch TodaySeptember 24th - MarketBeat
Stifel Raises Price Target for uniQure (QURE) to 65.00 USD | QUR - GuruFocus
2.43%
大文字化:
|
ボリューム (24 時間):